
Medtronic (MDT) Stock Forecast & Price Target
Medtronic (MDT) Analyst Ratings
Bulls say
Medtronic is well-positioned for growth with the expansion of its product portfolio, including the new Symplicity Spyral system, and its strong leadership. The company's financials have been consistently strong, and despite potential challenges, analysts have a positive outlook for its future performance. With their upcoming Analyst Day, investors can expect to learn more about the company's long-term growth targets and potential for continued growth in the mid-single-digit range.
Bears say
Medtronic is a leading medical device company that engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. Despite its robust portfolio of products and global presence, Medtronic's stock is likely to face challenges in the near term due to unsuccessful new product launches and potential market share losses in certain product categories. Additionally, the company's growing dependence on state supplemental programs and potential inflationary risks could negatively impact its earnings growth and margins. Overall, our negative outlook is based on the potential for slower revenue and earnings growth, as well as increased competition in key market segments.
This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.
Medtronic (MDT) Analyst Forecast & Price Prediction
Start investing in Medtronic (MDT)
Order type
Buy in
Order amount
Est. shares
0 shares